
WSH in the News


Patent Case Against Gilead Reopened; Result Could Remove Share Overhang
If GILD is successful in reducing this case's judgment or having it dismissed, it would remove some of the overhang affecting the share price...
Read More

A Few Key Points I Am Focusing On From Gilead Sciences' Upcoming Earnings Release
GILD's first-quarter earnings release [on 4/28, confirmed by Wall Street Horizon on 4/4] remains the most widely anticipated event of the quarter...
Read More
Data-as-a-Service Analytics Startup Kyper Taps WSH for Events Data
Kyper has incorporated content from Wall Street Horizon into its platform, to allow users to consider events data alongside other sources to create predictive signals based on historical analysis.
Read More
Updating My Outlook On Pfizer In Light Of The Recent Termination Of The Allergan Merger
See how corporate events such as upcoming the earnings announcement affect the outlook for PFE..
Read More
Regeneron Pharmaceuticals Is My Top Pick In The Biotech Space
Article includes shapshot of corporate event data from Wall Street Horizon as it factors into the analysis of REGN...
Read More
My Thoughts On Gilead Sciences' Patent Loss
How will Gilead's forthcoming earnings release impact the share price? Check out Seeking Alpha's detailed analysis...
Read More